Invasive breast cancer following bilateral subcutaneous mastectomy in a BRCA2 mutation carrier: A case report and review of the literature

World Journal of Surgical Oncology

Volumn 3, Issue , 2005, Pages

  Kasprzak, Lidia ^a   Mesurolle, Benoit ^a   Tremblay, Francine ^b   Galvez, Maria ^a   Halwani, Fawaz ^b   Foulkes, William D ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; BREAST CANCER; CANCER INVASION; CANCER PREVENTION; CASE REPORT; FEMALE; FOLLOW UP; GENE MUTATION; HETEROZYGOTE; HUMAN; LONG TERM CARE; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; POSTOPERATIVE PERIOD; REVIEW; RISK BENEFIT ANALYSIS; SUBCUTANEOUS MASTECTOMY; SURGICAL TECHNIQUE;

EID: 27444443589     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-3-52     Document Type: Review

References (17)

1. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995, 56:265-271.
2. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, Neuhausen SL, Ford D, Wooster R, Cannon-Albright LA, Stratton MR, Goldgar DE: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997, 61:120-128.
3. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001, 93:1633-1637.
4. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001, 345:159-164.
5. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004, 22:1055-1062.
6. Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA: Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 1998, 63:1341-1351.
7. Brinton LA, Persson I, Boice JD Jr, McLaughlin JK, Fraumeni JF Jr: Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 2001, 91:478-483.
8. Simmons RM, Adamovich TL: Skin-sparing mastectomy. Surg Clin North Am 2003, 83:885-899.
9. Metcalfe KA, Semple JL, Narod SA: Time to reconsider subcutaneous mastectomy for breast-cancer prevention? Lancet Oncol 2005, 6:431-4.
10. Pennisi VR, Capozzi A: Subcutaneous mastectonny data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg 1989, 13:15-21.
11. Slade CL: Subcutaneous mastectomy: acute complications and long-term follow-up. Plast Reconstr Surg 1984, 73:84-90.
12. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999, 340:77-84.
13. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Chang-Claude J, Sobol H, Weber B, Stratton MR, Easton DF: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998, 90:1138-1145.
14. Kaas R, Kroger R, Hendriks JH, Besnard AP, Koops W, Pameijer FA, Prevoo W, Loo CE, Muller SH: The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. Eur Radiol 2004, 14:1647-53.
15. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA: Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995, 196:123-134.
16. Giovagnorio F, Andreoli C, De Cicco ML: Color Doppler sonography of focal lesions of the skin and subcutaneous tissue. J Ultrasound Med 1999, 18:89-93.
17. Lamb PM, Perry NM, Vinnicombe SJ, Wells CA. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol 2000, 55:40-44.